Table 1.

Patient demographics and prestudy therapy details

Demographic	Patients previously receiving human premix ± OADs (n=3856)
Age (years)	57.0 ± 11.5
Gender, male/female (%)	2230/1623 (57.9/42.1%)
BMI (kg/m2)	26.3 ± 4.9
Duration of diabetes (years)	10.7 ± 6.9
Prestudy BHI 30 dose
lU	33.4 ± 17.8
lU/kg	0.49 ± 0.24
Percentage of patients injecting BHI 30 once/twice/three/four times daily prestudy (%)	11.4/84.0/4.4/0.2
Percentage of patients receiving 1, 2, > 2 OADs prestudy (%)*	26/38/16

Data are mean ± SD unless stated otherwise.

^*OAD information missing for 20% of patients. BMI, body mass index; BHI, biphasic human insulin 30; OAD, oral antidiabetic drug.